UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Genetic Polymorphisms of the TGFB1 Signal Peptide and Promoter Region: Role in Wilms Tumor Susceptibility?

Journal of kidney cancer and VHL, 2021-10, Vol.8 (4), p.22-31

2021

Volltextzugriff (PDF)

Genetic polymorphism in FOXP3 gene: imbalance in regulatory T-cell role and development of human diseases

Journal of genetics, 2013-04, Vol.92 (1), p.163-171

2013

Volltextzugriff (PDF)

CXCL12 chemokine and CXCR4 receptor: association with susceptibility and prognostic markers in triple negative breast cancer

Molecular biology reports, 2018-10, Vol.45 (5), p.741-750

2018

Volltextzugriff (PDF)

Transforming growth factor beta 1 (TGFβ1) polymorphisms and haplotype structures have dual roles in breast cancer pathogenesis

Journal of cancer research and clinical oncology, 2018-04, Vol.144 (4), p.645-655

2018

Volltextzugriff (PDF)

Role of CXCL12 and CXCR4 in normal cerebellar development and medulloblastoma

International journal of cancer, 2016-01, Vol.138 (1), p.10-13

2016

Volltextzugriff (PDF)

Mouse Mammary Tumor Virus (MMTV)-Like env Sequence in Brazilian Breast Cancer Samples: Implications in Clinicopathological Parameters in Molecular Subtypes

International journal of environmental research and public health, 2020-12, Vol.17 (24), p.9496

2020

Volltextzugriff (PDF)

Genetic Polymorphism and Expression of CXCR4 in Breast Cancer

Analytical cellular pathology (Amsterdam), 2015-01, Vol.2015, p.289510-8

2015

Volltextzugriff (PDF)

Transforming growth factor beta 1 (TGFβ1) plasmatic levels in breast cancer and neoplasia-free women: Association with patients’ characteristics and TGFB1 haplotypes

Cytokine (Philadelphia, Pa.), 2020-06, Vol.130, p.155079-155079, Article 155079

2020

Volltextzugriff (PDF)

FOXP3 Allelic Variants and Haplotype Structures Are Associated with Aggressive Breast Cancer Subtypes

Disease markers, 2017-01, Vol.2017, p.6359603-8

2017

Volltextzugriff (PDF)

TGFβ1 pathway components in breast cancer tissue from aggressive subtypes correlate with better prognostic parameters in ER-positive and p53-negative cancers

Surgical and experimental pathology, 2021-09, Vol.4 (1), p.1-13, Article 14

2021

Volltextzugriff (PDF)

Glutathione S-transferases deletions may act as prognosis and therapeutic markers in breast cancer

Clinical and experimental medicine, 2018-02, Vol.18 (1), p.27-35

2018

Volltextzugriff (PDF)

HER2 Ile655Val polymorphism is negatively associated with breast cancer susceptibility

Journal of clinical laboratory analysis, 2018-07, Vol.32 (6), p.e22406-n/a

2018

Volltextzugriff (PDF)

Immunohistochemical Expression of CXCR4 on Breast Cancer and Its Clinical Significance

Analytical cellular pathology (Amsterdam), 2015-01, Vol.2015, p.891020-6

2015

Volltextzugriff (PDF)

Genetic Polymorphism in the Promoter Region of Serotonin Transporter: Implications for Ethanol Abuse in Children and Adolescents

Journal of the Canadian Academy of Child and Adolescent Psychiatry, 2016-01, Vol.25 (1), p.43-49

2016

Volltextzugriff (PDF)

Protein Expression and Codon 72 Polymorphism of TP53 Gene in Triple Negative Breast Cancer

Brazilian Archives of Biology and Technology, 2014-12, Vol.57 (6), p.895-899

LOPES, Leandra Fiori

2014

Volltextzugriff (PDF)

Interferon-gamma plasma levels and presence of mouse mammary tumor virus-like env gene: Implications on the pathogenesis of breast cancer

Cytokine (Philadelphia, Pa.), 2023-09, Vol.169, p.156299-156299, Article 156299

2023

Volltextzugriff (PDF)

Molecular Markers for Breast Cancer: Prediction on Tumor Behavior

Disease markers, 2014-01, Vol.2014, p.513158-12

2014

Volltextzugriff (PDF)

Authors' reply to the comment "Transforming growth factor beta receptor II

Breast cancer research and treatment, 2020-01, Vol.179 (2), p.519

2020

Volltextzugriff (PDF)

Transforming growth factor beta receptor II

Breast cancer research and treatment, 2019-11, Vol.178 (1), p.207

2019

Volltextzugriff (PDF)

Identification of the novel HLA-DRB303:69 allele by next-generation sequencing

HLA, 2024-08, Vol.104 (2), p.e15646

2024

Volltextzugriff (PDF)

The novel HLA‐DPA101:182 allele identified in a Brazilian bone marrow donor

HLA, 2024-04, Vol.103 (4), p.e15470-n/a

2024

Volltextzugriff (PDF)

Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism in Brazilian breast cancer patients: association with susceptibility, clinicopathological features, and interaction with TGFB1 haplotypes

Breast cancer research and treatment, 2019-11, Vol.178 (1), p.207-219

2019

Volltextzugriff (PDF)

Germline APOBEC3B deletion influences clinicopathological parameters in luminal-A breast cancer: evidences from a southern Brazilian cohort

Journal of cancer research and clinical oncology, 2020-06, Vol.146 (6), p.1523-1532

2020

Volltextzugriff (PDF)

Authors’ reply to the comment “Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism”

Breast cancer research and treatment, 2020, Vol.179 (2), p.519-520

2020

Volltextzugriff (PDF)

The novel HLA‐A68:190:02 allele identified in a Brazilian bone marrow donor

HLA, 2024-01, Vol.103 (1), p.e15343-n/a

2024

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Genetic Polymorphisms of the TGFB1 Signal Peptide and Promoter Region: Role in Wilms Tumor Susceptibility?

Genetic polymorphism in FOXP3 gene: imbalance in regulatory T-cell role and development of human diseases

CXCL12 chemokine and CXCR4 receptor: association with susceptibility and prognostic markers in triple negative breast cancer

Transforming growth factor beta 1 (TGFβ1) polymorphisms and haplotype structures have dual roles in breast cancer pathogenesis

Role of CXCL12 and CXCR4 in normal cerebellar development and medulloblastoma

Mouse Mammary Tumor Virus (MMTV)-Like env Sequence in Brazilian Breast Cancer Samples: Implications in Clinicopathological Parameters in Molecular Subtypes

Genetic Polymorphism and Expression of CXCR4 in Breast Cancer

Transforming growth factor beta 1 (TGFβ1) plasmatic levels in breast cancer and neoplasia-free women: Association with patients’ characteristics and TGFB1 haplotypes

FOXP3 Allelic Variants and Haplotype Structures Are Associated with Aggressive Breast Cancer Subtypes

TGFβ1 pathway components in breast cancer tissue from aggressive subtypes correlate with better prognostic parameters in ER-positive and p53-negative cancers

Glutathione S-transferases deletions may act as prognosis and therapeutic markers in breast cancer

HER2 Ile655Val polymorphism is negatively associated with breast cancer susceptibility

Immunohistochemical Expression of CXCR4 on Breast Cancer and Its Clinical Significance

Genetic Polymorphism in the Promoter Region of Serotonin Transporter: Implications for Ethanol Abuse in Children and Adolescents

Protein Expression and Codon 72 Polymorphism of TP53 Gene in Triple Negative Breast Cancer

Interferon-gamma plasma levels and presence of mouse mammary tumor virus-like env gene: Implications on the pathogenesis of breast cancer

Molecular Markers for Breast Cancer: Prediction on Tumor Behavior

Authors' reply to the comment "Transforming growth factor beta receptor II

Transforming growth factor beta receptor II

Identification of the novel HLA-DRB303:69 allele by next-generation sequencing

The novel HLA‐DPA101:182 allele identified in a Brazilian bone marrow donor

Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism in Brazilian breast cancer patients: association with susceptibility, clinicopathological features, and interaction with TGFB1 haplotypes

Germline APOBEC3B deletion influences clinicopathological parameters in luminal-A breast cancer: evidences from a southern Brazilian cohort

Authors’ reply to the comment “Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism”

The novel HLA‐A68:190:02 allele identified in a Brazilian bone marrow donor

Suchergebnisse filtern